Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_assertion type Assertion NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_head.
- NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_assertion wasGeneratedBy ECO_0000203 NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_provenance.
- NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_assertion wasDerivedFrom befree-2016 NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_provenance.
- NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_assertion SIO_000772 24065731 NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_provenance.
- NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_assertion evidence source_evidence_literature NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_provenance.
- NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_assertion description "[Patients with non-small cell lung cancer (NSCLC) with activating EGF receptor (EGFR) mutations initially respond to first-generation reversible EGFR tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1113442.RAohXmaNs9fSfBtQWaETSK6FoXQxvFjn6zP2j35K1J4eY130_provenance.